S-Series Brochure
Perimeter S-Series OCT (Optical Coherence Tomography) is a pioneering medical imaging system that provides cross-sectional, real-time margin visualization of excised tissue specimens in the operating room.
No resources found with chosen filters
Perimeter S-Series Product Information
What is OCT? Information Sheet
OCT is a non-invasive optical imaging technique that produces images of subsurface tissue structures. Analogous to ultrasound, it uses light instead of sound, resulting in 10x higher resolution. This brochure provides more information on the benefits of OCT and how it works.
Share this item by copying the URL and link below:
What is OCT? Information Sheet:
https://perimetermed.com/wp-content/uploads/2022/03/How-OCT-Works.pdf
Clinical Resources
Potential Utility of Adjunct Imaging with Wide‑Field Optical Coherence Tomography for Gross and Microscopic Evaluation of Breast Specimens in Real‑Time in the Operating Suite
This paper reports on the intraoperative use of Optical Coherence Tomography (OCT) in 3 patients with DCIS. In all 3 cases, additional lesions identified by OCT during surgery were also noted in histopathology reports 3 to 5 days post-surgery, suggesting that intraoperative use of OCT is a valuable tool for margin determination in real-time. (DuPree, et al, 2021)
Updated: August 6, 2021
Share this item by copying the URL and link below:
Potential Utility of Adjunct Imaging with Wide‑Field Optical Coherence Tomography for Gross and Microscopic Evaluation of Breast Specimens in Real‑Time in the Operating Suite:
https://f.hubspotusercontent10.net/hubfs/8553963/Indian%20Journal%20of%20Surgery%20Paper-DuPree.pdf
Evaluation of surgically excised breast tissue microstructure using wide-field Optical Coherence Tomography
In this pilot study, evaluation of wide-field Optical Coherence Tomography demonstrated concordance with histology at tissue margins, supporting its potential for use as a real-time adjunct intraoperative imaging tool for margin assessment in surgically excised breast tissue. (Schmidt, et al, 2019)
Updated: October 14, 2019
Share this item by copying the URL and link below:
Evaluation of surgically excised breast tissue microstructure using wide-field Optical Coherence Tomography:
https://pubmed.ncbi.nlm.nih.gov/31612563/
Optical Coherence Tomography: A Novel Imaging Method for Post-lumpectomy Breast Margin Assessment—A Multi-reader Study
Study results display the potential for Optical Coherence Tomography (OTC) as a real-time intraoperative tool for post-lumpectomy specimen margin assessment. This study revealed a relatively short training time and showed that readers from different medical specialties were able to distinguish suspicious from non-suspicious OCT imaging findings in ex vivo breast tissue confirmed by histology. (Ha, et al, 2017)
Updated: March 1, 2018
Share this item by copying the URL and link below:
Optical Coherence Tomography: A Novel Imaging Method for Post-lumpectomy Breast Margin Assessment—A Multi-reader Study:
https://www.academicradiology.org/article/S1076-6332(17)30411-7/fulltext
Feasibility Study of the Intra-operative Use of the OTIS™, Wide Field Optical Coherence Tomography (WF-OCT) in Surgically Excised Partial-mastectomy Breast Tissue
This abstract presents the effectiveness of lumpectomy specimen stabilization with a compression bag using Perimeter’s OTIS™ Optical Coherence Tomography (OTC) device. The use of compression to improve lumpectomy specimen imaging did not compromise specimen integrity for pathology and showed no statistical difference in re-excision rates. The OTIS™ OCT device seamlessly integrated into the intraoperative workflow for breast specimen imaging. (PAGE 187, Wilke, et al, 2020)
Share this item by copying the URL and link below:
Feasibility Study of the Intra-operative Use of the OTIS™, Wide Field Optical Coherence Tomography (WF-OCT) in Surgically Excised Partial-mastectomy Breast Tissue :
https://www.breastsurgeons.org/education/virtual/proceedings.pdf#page=187
Is OCT the Next Game Changer in Margin Visualization?
Presenting multiple patient cases using a new FDA-cleared intraoperative specimen imaging technology for real-time visualization of excised tissue and shaved margins with surgeons from three prestigious institutions involved in Perimeter’s clinical trials. This webinar provides a deeper dive on Optical Coherence Tomography (OCT) – an established, ultra-high-resolution technology used in cardiology, dermatology, and ophthalmology – and correlates OCT images to histopathology.
Presented by Nina Tamirisa, MD, Maryam Elmi, MD, and Stacey Carter, MD, FACS
Share this item by copying the URL and link below:
Is OCT the Next Game Changer in Margin Visualization? :
https://oct.perimetermed.com/asbrs-october-2021-webinar
Next Generation in Surgical Specimen Imaging with Future AI Enhancements
Learn more about advancements in intraoperative specimen imaging. Optical Coherence Tomography (OCT), a high resolution imaging modality commonly used in ophthalmology and cardiology, is ideally suited to visualizing margins during a surgical procedure. This webinar also includes insights into how Artificial Intelligence is moving towards the OR and Specimen Imaging.
Presented by Dr. Hank Schmidt, Dr. Beth DuPree, and Dr. Alastair Thompson
Share this item by copying the URL and link below:
Next Generation in Surgical Specimen Imaging with Future AI Enhancements:
https://oct.perimetermed.com/asbrs-webinar
General Resources
Dr. DuPree's experience using Perimeter's technology in a clinical trial
Dr. DuPree discusses her experience using Perimeter's OCT technology in a clinical trial. You'll hear her describe how Perimeter aims to solve the problem of real-time margin visualization with its groundbreaking technology and how she incorporates our device into her intraoperative workflow.
Mary's Story
Mary Leas discusses her breast cancer diagnosis and involvement in a clinical trial using Perimeter’s technology.
Suzanne's Story
Hear Suzanne talk about the fear she experienced with her cancer diagnosis and being called back for a second surgery.
Jenn's Story
Jenn describes how her battle with cancer affected her outlook on life.
Jessie's Story
Jessie Henson discusses her breast cancer diagnosis and involvement in a clinical trial using Perimeter’s technology.
Perimeter Does
Traditional intraoperative imaging modalities do not deliver the resolution to visualize microscopic features associated with cellular-level disease. Perimeter is looking to become the answer to intraoperative margin visualization with its OCT technology.
Perimeter S-Series OCT Introduction
Our flagship product, Perimeter S-Series OCT (Optical Coherence Tomography) is a pioneering medical imaging system that provides cross-sectional, real-time margin visualization of excised tissue specimens in the operating room (OR).
Corporate Introduction
Jeremy Sobotta, CEO, introduces Perimeter Medical Imaging AI, a medical technology company driven to transform cancer surgery by developing advanced imaging systems that improve the standard of care, provide better long-term outcomes for patients and reduce healthcare costs.
2021 Year in Review
From FDA clearance of Perimeter Medical Imaging AI's S-Series OCT device to our first commercial installation and the launch of our pivotal trial, 2021 was a year full of milestones. With this momentum, we’ll continue our mission to transform cancer surgery and improve patients’ lives in 2022.
Perimeter Overview
Perimeter Medical Imaging AI provides the medical community with innovative imaging tools needed to build confidence in the operating room.
Share this item by copying the URL and link below:
Perimeter Overview:
https://perimetermed.com/wp-content/uploads/2022/03/Perimeter-Overview.pdf
What's New
Perimeter Does Video